APA (7th ed.) Citation

Takada, K., Kashiwagi, S., Nishikawa, M., Kochi, A., Watanabe, C., Kinoshita, H., . . . Morisaki, T. (2025). Differences in Sentinel lymph node biopsy outcomes and prognosis between HER2-low and HER2-zero breast cancer. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14970-8

Chicago Style (17th ed.) Citation

Takada, Koji, Shinichiro Kashiwagi, Mariko Nishikawa, Asuka Kochi, Chika Watanabe, Haruhito Kinoshita, Kana Ogisawa, Masatsune Shibutani, and Tamami Morisaki. "Differences in Sentinel Lymph Node Biopsy Outcomes and Prognosis Between HER2-low and HER2-zero Breast Cancer." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14970-8.

MLA (9th ed.) Citation

Takada, Koji, et al. "Differences in Sentinel Lymph Node Biopsy Outcomes and Prognosis Between HER2-low and HER2-zero Breast Cancer." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14970-8.